Company Filing History:
Years Active: 2024
Title: Innovations in Pharmaceutical Compositions: The Contributions of Thomas Wallace Lategan
Introduction
Thomas Wallace Lategan, an inventive spirit based in New Orleans, LA, has made significant strides in the field of pharmaceuticals. With his keen focus on enhancing gastrointestinal tolerability in medication, Lategan has contributed valuable knowledge and solutions to the treatment of multiple sclerosis.
Latest Patents
Lategan holds one patent titled "Fumarate Ester Dosage Forms with Enhanced Gastrointestinal Tolerability." This invention details pharmaceutical compositions that incorporate one or more fumarate esters, notably focusing on reducing gastrointestinal side effects when treating multiple sclerosis patients compared to existing treatments that include dimethyl fumarate, such as TECFIDERA®. His innovative approach involves utilizing oral pharmaceutical compositions that feature monomethyl fumarate within a liquid vehicle, thereby minimizing discomfort typically associated with gastrointestinal issues.
Career Highlights
Currently, Thomas Wallace Lategan is affiliated with Banner Life Sciences LLC, where he continues to drive research and development efforts. His work within the pharmaceutical industry emphasizes the importance of patient comfort and the efficacy of treatments. This underscores his commitment to improving the lives of those affected by chronic illnesses.
Collaborations
Lategan has collaborated with notable colleagues such as Franck S. F. Rousseau and Tiffany Nicole Sprague. These partnerships highlight the importance of teamwork in advancing pharmaceutical innovations and ensuring that research efforts lead to practical and beneficial applications in medical treatments.
Conclusion
Through his patent and collaborative efforts, Thomas Wallace Lategan exemplifies the role of inventors in the pharmaceutical industry. His focus on reducing gastrointestinal side effects paves the way for a better quality of life for multiple sclerosis patients. As innovations continue to emerge from his work at Banner Life Sciences LLC, the future looks promising for advancements in medication that prioritize patient well-being.